Upton’s opening remarks at Full Committee Markup
Washington, October 17, 2019 | Josh Paciorek (202-225-3761)
WASHINGTON, DC – Energy Subcommittee Republican Leader Fred Upton (R-MI) delivered the following opening remarks today at a full committee markup, highlighting his concerns over HR 3, the Lower Drug Costs Now Act of 2019.
Remarks as Prepared for Delivery
“MR CHAIRMAN. Every member in this room has been hearing from our constituents about the high cost of drugs. We passed legislation earlier this year to address several major causes of high prices, including increasing transparency and ending practices that were delaying generics from coming to market. We know those bills were just a start, which is why Republicans and Democrats on this committee were working together on more major legislation, including a complete redesign of the Part D program.
“Unfortunately, all that collaboration stopped when HR 3 had only one subcommittee hearing and no subcommittee markup. Instead of working together to find solutions that would immediately reduce the prices our constituents pay out of pocket for drugs, we are faced with legislation that has no chance of being signed into law and that would absolutely stifle innovation during a critical time when new and revolutionary cures and treatments are being developed.
“I hope that we can get both sides back to the table and we can come up with real solutions that help our constituents right away without taking away the promise of new cures for the people that we love